Artificial Intelligence for Ovarian Tumours

AI-Driven clinical decision support for enhanced Ovarian Cancer detection through Deep Learning on Ultrasound Images.

Empowering Precision in Gynecological Care

Bridging the Expertise Gap with Intelligyn.

1 in 10 women will have an ovarian tumour in their lifetime.

More than 50% of these occur in women of reproductive age. Unnecessary surgeries risk fertility loss, while delayed diagnoses can be devastating.

A shortage of specialised practitioners capable of accurately distinguishing between benign ovarian lesions and cancer exists.

Enter Intelligyn, your diagnostic partner, using AI for real-time feedback during ultrasound exams. Intelligyn bridges expertise gaps, ensuring accurate diagnoses, reducing costs and detecting malignancies earlier.

Join us in elevating women’s health. Together, we set new standards of care.

For women, everywhere.

Global Women’s Health Equity
Advancing universal access for women’s optimal health.

Economic Impact with Early Diagnosis
Enhancing patient outcomes, reducing treatment costs, and streamlining healthcare expenses.

Precision Care for Timely Detection
Elevating the diagnostic accuracy of all examinations, ensuring earlier diagnosis.

Diagnostic Collaboration
Our cloud-based platform offers vendor and platform neutrality and fosters advanced diagnostics for everyone.

Our partners